Insider · CIK 0001517775
Willis C Lee
Files at EMMA (Emmaus Life Sciences, Inc.). First filing Sep 2, 2026, latest Sep 2, 2026.
Willis C Lee files SEC Form 4 as CEO and director at EMMA (Emmaus Life Sciences, Inc.). Since Sep 2, 2026, Willis C Lee has reported 1 open-market buy worth $18k and 0 open-market sells worth $0, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Willis C Lee has 0, so none is measured yet.
The newest scored trade: bought $18k of EMMA on May 30, 2025, filed Sep 2, 2026, scored 35 (weak). In the last 12 months: 1 buy worth $18k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EMMA: Emmaus Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | EMMAbuy Emmaus Life Sciences, Inc. | $18k 530,767 shares | +333% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +70,000 | $0.02 | $1,400 | 229,400 | 41 d ago |
| Aug 29, 2025 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +170,000 | $0.01 | $1,700 | 275,400 | 41 d ago |
| Aug 25, 2026 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +46,000 | $0.04 | $1,840 | 445,400 | 41 d ago |
| Aug 27, 2026 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +50,000 | $0.05 | $2,500 | 495,400 | 41 d ago |
| Aug 28, 2026 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +94,767 | $0.06 | $5,686 | 590,167 | 41 d ago |
| Aug 31, 2026 | EMMA Emmaus Life Sciences, Inc. | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +100,000 | $0.05 | $5,000 | 690,167 | 41 d ago |
Questions about Willis C Lee
Answered from the filings on this page, as of the latest one.
Is Willis C Lee buying or selling?
In the last 12 months Willis C Lee reported 1 open-market buy worth $18k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $18k of EMMA on May 30, 2025. Grants, option exercises and tax withholding are not counted.
How did Willis C Lee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Willis C Lee has 0.
Where does Willis C Lee file Form 4?
Willis C Lee has filed Form 4 at EMMA (Emmaus Life Sciences, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.